U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840860) titled 'Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)' on Feb. 10.
Brief Summary: This study aims to better understand how mpox is spreading in the DRC, how it affects different groups of people, and how well vaccines protect against it. The study is designed as a cross-sectional survey, meaning researchers will collect and analyze data from patients diagnosed with mpox at a single point in time. It will also use a case-control approach, comparing people who test positive for the virus to those who test negative, to identify risk factors and evaluate the effectiveness of the vaccine.
Study Start Da...